SAA1 and pancreatic neoplasm: Interestingly, SAA1, an acute phase protein that associates with and potentially decreases the efflux capacity of HDL particles (34), was highly enriched in plasma samples of pancreatic-cancer patients, thereby reducing the APOA1-to-SAA1 ratio in those patients (Fig 6F).